Community-acquired pneumonia (CAP) is one of the most common life-threatening infections, with most deaths occurring in developing countries. 1 India accounts for 23% of the global pneumonia burden, and 36% of the WHO regional burden. 2 Evidence suggests that ceftaroline fosamil is an effective and well-tolerated treatment in CAP patients. 3 In this regard, the present article describes a case of a man, who was effectively managed with ceftaroline fosamil. Case Presentation*: A 66-year-old man was admitted to the hospital after a 4-day history of dry cough, progressing to rusty colored sputum.
He further reported the symptoms such as fever, malaise, and sudden onset of chills from the previous evening. Initially, the man thought that he was suffering from cold. However, these symptoms worsened. He also reported disturbed sleep a night before admission because of severe…
